Cargando…

Efficacy of Casirivimab/Imdevimab in Kidney Transplant Recipients Admitted with Mild-to-Moderate COVID-19: A Case Series

Detalles Bibliográficos
Autores principales: Rajmane, Siddhavinayak Suryakant, Patil, Ashwin Arunkumar, Dash, Choudhary Sudhiranjan, Bahadur, Madan M., Shingare, Ashay, Deshpande, Rushi Vijaykumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593297/
https://www.ncbi.nlm.nih.gov/pubmed/37881734
http://dx.doi.org/10.4103/ijn.ijn_300_22
_version_ 1785124422873513984
author Rajmane, Siddhavinayak Suryakant
Patil, Ashwin Arunkumar
Dash, Choudhary Sudhiranjan
Bahadur, Madan M.
Shingare, Ashay
Deshpande, Rushi Vijaykumar
author_facet Rajmane, Siddhavinayak Suryakant
Patil, Ashwin Arunkumar
Dash, Choudhary Sudhiranjan
Bahadur, Madan M.
Shingare, Ashay
Deshpande, Rushi Vijaykumar
author_sort Rajmane, Siddhavinayak Suryakant
collection PubMed
description
format Online
Article
Text
id pubmed-10593297
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-105932972023-10-25 Efficacy of Casirivimab/Imdevimab in Kidney Transplant Recipients Admitted with Mild-to-Moderate COVID-19: A Case Series Rajmane, Siddhavinayak Suryakant Patil, Ashwin Arunkumar Dash, Choudhary Sudhiranjan Bahadur, Madan M. Shingare, Ashay Deshpande, Rushi Vijaykumar Indian J Nephrol Research Letter Wolters Kluwer - Medknow 2023 2023-06-05 /pmc/articles/PMC10593297/ /pubmed/37881734 http://dx.doi.org/10.4103/ijn.ijn_300_22 Text en Copyright: © 2023 Indian Journal of Nephrology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Research Letter
Rajmane, Siddhavinayak Suryakant
Patil, Ashwin Arunkumar
Dash, Choudhary Sudhiranjan
Bahadur, Madan M.
Shingare, Ashay
Deshpande, Rushi Vijaykumar
Efficacy of Casirivimab/Imdevimab in Kidney Transplant Recipients Admitted with Mild-to-Moderate COVID-19: A Case Series
title Efficacy of Casirivimab/Imdevimab in Kidney Transplant Recipients Admitted with Mild-to-Moderate COVID-19: A Case Series
title_full Efficacy of Casirivimab/Imdevimab in Kidney Transplant Recipients Admitted with Mild-to-Moderate COVID-19: A Case Series
title_fullStr Efficacy of Casirivimab/Imdevimab in Kidney Transplant Recipients Admitted with Mild-to-Moderate COVID-19: A Case Series
title_full_unstemmed Efficacy of Casirivimab/Imdevimab in Kidney Transplant Recipients Admitted with Mild-to-Moderate COVID-19: A Case Series
title_short Efficacy of Casirivimab/Imdevimab in Kidney Transplant Recipients Admitted with Mild-to-Moderate COVID-19: A Case Series
title_sort efficacy of casirivimab/imdevimab in kidney transplant recipients admitted with mild-to-moderate covid-19: a case series
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593297/
https://www.ncbi.nlm.nih.gov/pubmed/37881734
http://dx.doi.org/10.4103/ijn.ijn_300_22
work_keys_str_mv AT rajmanesiddhavinayaksuryakant efficacyofcasirivimabimdevimabinkidneytransplantrecipientsadmittedwithmildtomoderatecovid19acaseseries
AT patilashwinarunkumar efficacyofcasirivimabimdevimabinkidneytransplantrecipientsadmittedwithmildtomoderatecovid19acaseseries
AT dashchoudharysudhiranjan efficacyofcasirivimabimdevimabinkidneytransplantrecipientsadmittedwithmildtomoderatecovid19acaseseries
AT bahadurmadanm efficacyofcasirivimabimdevimabinkidneytransplantrecipientsadmittedwithmildtomoderatecovid19acaseseries
AT shingareashay efficacyofcasirivimabimdevimabinkidneytransplantrecipientsadmittedwithmildtomoderatecovid19acaseseries
AT deshpanderushivijaykumar efficacyofcasirivimabimdevimabinkidneytransplantrecipientsadmittedwithmildtomoderatecovid19acaseseries